Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Routine or delayed axillary dissection for primary breast cancer?

R J Epstein1

  • 1Department of Medical Oncology, Charing Cross Hospital, London, U.K.

European Journal of Cancer (Oxford, England : 1990)
|September 1, 1995
PubMed
Summary

Routine axillary dissection for breast cancer may not be necessary when patients receive systemic therapy. Delaying lymph node removal until needed could improve quality of life without compromising treatment effectiveness.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A randomised phase II trial of three dosing regimens of radium-223 in patients with bone metastatic castration-resistant prostate cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Resolution of paraneoplastic immune thrombocytopenia following everolimus treatment for metastatic renal cell carcinoma.

Internal medicine journal·2015
Same author

Intermittent androgen deprivation is a rational standard-of-care treatment for all stages of progressive prostate cancer: results from a systematic review and meta-analysis.

Prostate cancer and prostatic diseases·2014
Same author

Anticancer activity of combination targeted therapy using cetuximab plus vemurafenib for refractory BRAF (V600E)-mutant metastatic colorectal carcinoma.

Current oncology (Toronto, Ont.)·2014
Same author

Has discovery-based cancer research been a bust?

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2013
Same author

Death in The New York Times: the price of fame is a faster flame.

QJM : monthly journal of the Association of Physicians·2013

Area of Science:

  • Oncology
  • Surgical Oncology
  • Clinical Trials

Background:

  • Prophylactic lymph node excision is a standard procedure for preventing breast cancer recurrence.
  • Adjuvant systemic therapy benefits patients with axillary node metastases, reinforcing the rationale for lymph node assessment.
  • Medical opinions are divided on the necessity of routine axillary dissection, partly due to expectant adjuvant systemic therapy use.

Purpose of the Study:

  • To assess the net benefits of axillary dissection in patients receiving routine adjuvant systemic therapy.
  • To determine if delaying axillary dissection (salvage treatment) impacts outcomes compared to routine dissection.
  • To provide objective data to inform clinical decision-making regarding axillary dissection in breast cancer management.

Main Methods:

  • A controlled assessment comparing routine axillary dissection versus delayed (salvage) axillary treatment.
  • Evaluation of patients receiving adjuvant systemic therapy.
  • Analysis of oncological outcomes and quality of life.

Main Results:

  • Data on the comparative benefits of routine versus delayed axillary dissection in the context of adjuvant systemic therapy are currently lacking.
  • The study aims to quantify any potential loss of benefit by delaying dissection.
  • Potential for improved quality of life for a majority of breast cancer patients if delayed dissection is non-inferior.

Conclusions:

  • Objective data are urgently needed to resolve the debate on routine axillary dissection.
  • Replacing routine with delayed axillary dissection may offer significant quality of life improvements.
  • Further research is required to confirm the safety and efficacy of delayed axillary dissection in breast cancer patients receiving systemic therapy.

Related Experiment Videos